Navigation Links
Mass Leave By Doctors Leaves Patients Helpless

doing anything to help poor people get proper treatment," Gupta, 43, added.

In Lok Nayak Jai Prakash (LNJP) Hospital, which is part of MAMC, the situation was even worse. Hundreds of patients could be seen outside the OPD waiting for doctors.

"What is the point of having hospitals if they do not provide treatment to patients? It's the poor people who are caught between the politicians and the protesting doctors," said Anand Ahuja, who had come for an X-ray.

But Singh said emergency and ICU services were running fine at LNJP. "We are concerned about patients and ICU and emergency care is being carried out," he said.

The Supreme Court Monday issued a notice to the centre on the reservation issue. Hearing a petition filed by advocate Ashok Thakur, the court asked the centre to define the OBC tag and the basis on which it has decided to implement 27 percent caste-based reservation.

On Tuesday, the faculty at the All India Institute of Medical Science (AIIMS) has planned to go on a daylong hunger strike without affecting work. On Wednesday, the protesting medicos have called for a complete shutdown of all OPDs but emergency and casualty services will operate.

Students of the Indian Institute of Technology (Delhi) and Jawaharlal Nehru University (JNU) have also begun a relay hunger strike in their respective campuses.

--Edited IANS
'"/>




Page: 1 2

Related medicine news :

1. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
2. Stress Statistics May Leave You Stressed Out
3. A Man Taken To Court Due to His Refusal to Leave the Hospital
4. Bird Flu Fears Recede As Migratory Birds Leave
5. Strange Theft Of HIV Infected Blood Leaves Authorities Puzzled
6. Medical Faculty On Leave; JNU, IIT Students Join Hunger Strike
7. NHS Employees Score Over Other Private Staffs In Taking Leave
8. New Health care Plans to Leave NHS with White Elephants
9. Drug Denial may Leave Several Thousands Blind
10. Hotel Guests Often Leave Their Cold Behind
11. Anti Inflammatory Evaluation Of Plumeria Acuminata Leaves
Post Your Comments:
(Date:10/7/2008)...ty of life after discharge, study finds , ...edicine for intensive care unit (ICU) patients may...they,re able, a new report says. , Based on a ...ty School of Medicine researchers concluded that t...ause unnecessary and long-term physical impairment...
(Date:10/7/2008)...ely to enjoy better quality of life, study finds ,...nd-of-life discussions between a doctor and a term...for patients. In fact, they result in less aggress...life in a patient,s final days, a major new study ... has been around when, whether and how to have end...
(Date:10/7/2008)... -- Join Mii amo, a destination spa,at Enchantment...d rock,country honoring the winter solstice on Dec...al Native American ceremonies facilitated by Nativ...l guest, Elder George,Goodstriker., Goodstriker i...Reserve,in Standoff, Alberta, Canada,s largest res...
(Date:10/7/2008)...re/ -- Van Wert County Hospital, Van,Wert, Ohio, h...CARE(R),Corp.,s newest Emergency Department applic...al joins Conway Regional Medical Center, Conway,A..., Nashua, New Hampshire,in using OnRecord(TM) EDI... County Hospital began using OnRecord(TM) for all ...
Breaking Medicine News(10 mins):Health News:Early Mobility Best for ICU Patients 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 3Health News:Mii amo Honors Winter Solstice With Traditional Native American Celebration December 18-21 2Health News:Latest LOGICARE(R) EDIS User Sees 'Tremendous Results' 2
...a study published in the August issue of Neurology...ents are admitted to and discharged from the hospi...icantly. Studies have shown that several treatment...ount of disability, complications and the risk of ...
...a recent study researchers say that they found tha...te tumour cells in laboratory settings. Scientist...state cancer // could be due to a rapid increase i... the western diet in recent years. Omega-6 fats ha...
...shown that the efficacy of low-carb diets could be...chers question whether raising protein intake coul...esearchers set out to test the hypothesis that inc...bohydrate intake decreases the appetite, leads to ...
...he century started with a big bang, bringing hope ...ever, fate and nature had ideas of their own. 20...isasters and man made ones. The first internatio... February 1st in California when a jet bound for S...
Other Medicine News:Health News:Simple Procedural Improvements Can Improve Care Of Stroke Patients 2Health News:Finding The Key To Weight Loss! 2Health News:SARS (Bird Flu) spreading in the Asian continent 2
(Date:10/7/2008)...Prevented Immunologic Changes Induced by ...itional Data Indicates Potential in Treating Infla...ewswire/ -- Alba Therapeutics Corporation,presente...he American,College of Gastroenterology (ACG) 2008...001-004, the first Phase IIa trial conducted in ce...
(Date:10/7/2008)... ACG Annual Scientific Meeting -, ORLANDO, Fla., ...uticals, Inc. (formerly Microbia, Inc.) and Forest...the presentation of results from a Phase,2b study ... patients with,irritable bowel syndrome with const...at once- daily oral dosing of linaclotide, across ...
(Date:10/7/2008)...d Placebo-Controlled Phase II Study Shows ...al., MOUNTAIN VIEW, California, October 7 /PRNews...he mature Phase II data from the,therapeutic prost... been,obtained as part of the recently entered par...in the US., The results from the Phase II prospec...
(Date:10/7/2008)... /-, - 125 Patient, Prospe...,Shows Statistically Significant Improved Overall ...ature phase II data from the,therapeutic prostate ...n,obtained as part of the recently entered partner...he US., The results from the Phase II prospective...
Breaking Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 5Cultures role on alcohol and violence 26970 1Cultures role on alcohol and violence 26970 2Forest Laboratories Inc Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings 8032 1Forest Laboratories Inc Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings 8032 2Invest in Kids Rally to Be Held Before St Louis Vice Presidential Debate 26966 1Invest in Kids Rally to Be Held Before St Louis Vice Presidential Debate 26966 2The Scientific Business of Thomson Reuters Predicts Nobel Laureates 26962 1The Scientific Business of Thomson Reuters Predicts Nobel Laureates 26962 2The Scientific Business of Thomson Reuters Predicts Nobel Laureates 26962 3The Scientific Business of Thomson Reuters Predicts Nobel Laureates 26962 4The Scientific Business of Thomson Reuters Predicts Nobel Laureates 26962 5
...ire-FirstCall/ -,Neurochem (International) Limited...em Inc. , announces that the New England,Journal o...rodisate,For AA Amyloidosis Trial" (EFAAT), recogn...r a treatment of AA amyloidosis. The,results of th...TA(TM)) demonstrate that this product candidate of...
...007 - Gilead,Sciences, Inc. (Nasdaq:GILD) today an... evaluating the company,s once-daily,anti-HIV drug...r,DF) 300 mg as a potential treatment for chronic ... efficacy endpoint. The study shows,that Viread is...l,drug Hepsera(R) (adefovir dipivoxil) among patie...
Other Medicine Technology:Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 2Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 3Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 4Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 5Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 2Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 3Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 5Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 6Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 7
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: